Nitorol
® Injection is commercially available in glass bottles and ampoules. As it is often used in emergencies such as angina attacks and myocardial infarction, there has been a clinical need to develop a soft bag preparation. However, since the drug adsorbs onto the bag material, the development of a soft bag preparation had been considered impossible.
In recent years however, success was achieved in developing a soft bag preparation (Nitorol
® Injection Bag), and we assessed its usefulness in the clinical setting. In order to do this, pharmacists in our hospital compared preparatory procedures for administration between the bag and other administration forms, and a questionnaire was distributed to doctors, nurses, and pharmacists in order to investigate their opinions regarding safety, ease of use, risks, and cost.
The results of our assessment showed that the preparatory procedures for the administration of Nitorol
® Injection Bag were simpler than those for the Nitorol
® ampoule, which reduced risks, and regarding container material and container disposal costs, Nitorol
® Injection Bag was more economical. Further, the results of our questionnaire survey showed that Nitorol
® Injection Bag was superior in terms of safety, ease of use, and its convenience overall was highly rated.
抄録全体を表示